x
Visit our new Mobile Website next time you access NetDania with your mobile device

SAGE THERAPEUTICS INC. - COMMON STOCK

13.54
06-17:45:05 GMT
-0.40
-2.83%
ISIN:N/A

Figures - SAGE THERAPEUTICS INC. - COMMON STOCK

Open
14.00
Close
13.94
Year Change
-37.49
Year % Change
-37.49%
52 Week High
59.99
52 Week Low
10.92
Volume
231448
Inc. Vol
100

News - SAGE THERAPEUTICS INC. - COMMON STOCK

06-17:56 GMT
Consumer Sector Update for 05/06/2024: TSN, FRPT, DECK
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:56 GMT
Notable Monday Option Activity: DG, MU, ULTA
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:56 GMT
Notable Monday Option Activity: ADBE, AMD, AXON
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:56 GMT
Swiss Market Ends Higher Again
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:56 GMT
See Which Of The Latest 13F Filers Holds FedEx Corp
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:56 GMT
Tyson Foods (TSN) Q2 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:55 GMT
Respect Sustainable Lifestyles If You Respect Women
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:55 GMT
africaclip3.mp4
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:54 GMT
The World Is Watching: Studying Javier Milei
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:53 GMT
Cory Sandhagen Vs. Umar Nurmagomedov Set For UFC Abu Dhabi Fight Card
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:48 GMT
Real Madrid Star Bellingham Talks Position And Objectives At ‘Highest Level’ Club
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
Notable Monday Option Activity: ADBE, AMD, AXON
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
Earnings Estimates Moving Higher for Leidos (LDOS): Time to Buy?
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
Can Commvault (CVLT) Run Higher on Rising Earnings Estimates?
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
Upstart Holdings (UPST) to Report Q1 Earnings: What's in Store?
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
See Which Of The Latest 13F Filers Holds FedEx Corp
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
Crude Climbs After Saudi Arabia Hikes Oil Prices
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:42 GMT
Notable Monday Option Activity: DG, MU, ULTA
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:35 GMT
Founder Of Tia Adeola Shares How Living In Different Countries And Authenticity Helps Her Fashion Brand
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:34 GMT
Why Diversity Of Thought Is Needed In Business
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:34 GMT
Tracy Morgan Comedy ‘Crutch’ Ordered By Paramount+
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
How To Establish Trust In The AI Industry
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
A Psychologist Explains The ‘Power Couple Paradox’
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
Forget Nvidia: This Other "Magnificent Seven" Member Just Poured $11 Billion Into Data Centers
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
Here Are My Top 2 Stocks to Buy in May
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
European Stocks Close On Bright Note On Strong Data, Rate Cut Hopes
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:31 GMT
Monday's ETF with Unusual Volume: LDSF
Source: NASDAQ US Markets, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:30 GMT
Pearl Jam’s New Album Has Given The Band 90% Of All Their Hits On One Chart
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:25 GMT
3 Strategies For Mitigating Virtualization Platform Risk
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:20 GMT
How To Use Generative AI To Power Faster Innovation
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:19 GMT
20 AI-Powered Ideas For Building Sustainable Content Strategies
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:19 GMT
19 Ways To Communicate ‘Weaknesses’ In Job Interviews
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:16 GMT
Hamas Reportedly Agrees To Cease-Fire Proposal
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:16 GMT
Building Classrooms Using Recycled Plastic Blocks: Learnings From UNICEF
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
Smurfit Kappa (SMFKY) Upgraded to Strong Buy: Here's Why
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
MDU Resources (MDU) Upgraded to Strong Buy: Here's What You Should Know
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
All You Need to Know About Lamar (LAMR) Rating Upgrade to Strong Buy
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
Minerva Neurosciences (NERV) Upgraded to Buy: What Does It Mean for the Stock?
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
AudioEye (AEYE) Upgraded to Strong Buy: Here's Why
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
Monday's ETF with Unusual Volume: LDSF
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
See Which Of The Latest 13F Filers Holds JPMorgan Chase
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:14 GMT
Stocks Climb on Strength in Chips Stocks and Fed Rate Cut Optimism
Source: NASDAQ Stocks, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:10 GMT
Pastor survives attempted shooting during service
Source: BBC US-Canada, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:08 GMT
How Good Governance Can Help AI Grow
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:07 GMT
RFK Super PAC Planning Lawsuit Against Meta Over Blocked Ad—Which Meta Says Was ‘Quickly Restored’
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
06-17:03 GMT
U.S. Military Is Using Laser Weapons In Battle
Source: Forbes World, Symbol: SAGE THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38810.90
100.58
0.26%
5167.02
30.87
0.60%
18034.23
109.18
0.61%
63230.00
-791
-1.24%
18263.68
181.52
1.00%
38846.79
487.76
1.27%
3140.72
35.9
1.16%
8250.62
57.34
0.70%
18638.63
40.22
0.22%
7725.62
68.52
0.89%
22442.70
-33.15
-0.15%
2324.95
23.99
1.04%
83.13
0.325
0.39%
1.07738
0.00158
0.15%
153.903
0.955
0.62%
1.25643
0.00188
0.15%
0.66279
0.00198
0.30%
1.36615
-0.00233
-0.17%
165.81300
1.248
0.76%
0.85747
-0.00014
-0.02%
193.37200
1.484
0.77%
0.90599
0.00137
0.15%
0.97610
0.00389
0.40%
0.60142
0.00048
0.08%
105.05900
-0.037
-0.04%
Top Gainers
Name
Last
+/-
%
5.61
3.57
174.99%
0.13
0.06
79.81%
73.52
25.41
52.82%
3.19
1.07
50.50%
2.85
0.75
35.71%
0.02
0.00
34.78%
5.59
1.42
34.21%
2.75
0.64
30.33%
0.09
0.02
29.17%
7.22
1.60
28.51%
Top Losers
Name
Last
+/-
%
0.50
-3.53
-87.59%
0.36
-1.46
-80.06%
0.01
-0.01
-45.56%
0.03
-0.02
-41.54%
0.01
-0.01
-40.86%
12.02
-7.72
-39.11%
0.02
-0.01
-38.53%
0.02
-0.01
-38.43%
0.02
-0.02
-37.59%
0.18
-0.07
-27.96%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy